Seven immune signature genes (AKAP5, CTLA4, LRRC8C, AOAH-IT1, NPC2, RGS1, and SLC2A3) were used to develop the IAS for GC prognosis estimation. This evidence concerns the gene SLC2A3 and gastric cancer.